XRCC1 and glioma: In the end, our meta-analysis of 16 case-control studies indicated that XRCC1 Arg194Trp polymorphism probably was associated with increased risk of glioma, and the cumulative analysis suggested that the non-significant association would be change to significant if the sample sizes were enough.